Multicenter, randomized phase II trial of oral CI-1033 for previously treated advanced ovarian cancer.
Campos S, Hamid O, Seiden MV, Oza A, Plante M, Potkul RK, Lenehan PF, Kaldjian EP, Varterasian ML, Jordan C, Charbonneau C, Hirte H.
Campos S, et al. Among authors: charbonneau c.
J Clin Oncol. 2005 Aug 20;23(24):5597-604. doi: 10.1200/JCO.2005.08.091.
J Clin Oncol. 2005.
PMID: 16110019
Clinical Trial.